CRPC is defined as advanced prostate cancer associated with disease progression following surgical or pharmaceutical castration (i.e. continuous rise in serum prostate-specific antigen PSA levels, and/or appearance of new metastases) [11]. The gene discussed is KLK3; the disease is prostate cancer.